{
  "attach_pages": "5",
  "attach_size": "657",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP202006111384100212_1.pdf?1591865333000.pdf",
  "company_code": "80000038",
  "eitime": "2020-06-11 08:48:53",
  "extend": {},
  "info_code": "AP202006111384100212",
  "language": "0",
  "notice_date": "2020-06-11 00:00:00",
  "notice_title": "药明康德事件点评：会计核算变更带来净利润明显增益，看好细胞疗法CDMO领先地位",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "rating": "BB",
  "researcher": "孙建,郭双喜",
  "security": [
    {
      "market_uni": "1",
      "publish_relation": [
        {
          "originalCode": "727",
          "publishName": "医疗服务"
        }
      ],
      "short_name": "药明康德",
      "short_name_ch": "药明康德",
      "short_name_cht": "藥明康德",
      "short_name_en": "WUXI APPTEC",
      "stock": "603259"
    }
  ],
  "short_name": "药明康德",
  "source_sample_name": "民生证券",
  "star": "3"
}